Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes

NCT01562561 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: repaglinide
DRUG: insulin NPH

Sponsor

Novo Nordisk A/S